-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Management Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Limited Liability Clause
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
- Monitoring and Evaluation
- Principal Recipient Start-Up
-
Procurement and Supply Management
- Development of List of Health Products and Procurement Action Plan
- Distribution and Inventory Management
- Overview
- Price and Quality Reporting (PQR) System
- Procurement of Non-health Products and Services
- Procurement of Pharmaceutical and Other Health Products
- Quality Control
- Rational use of Medicines and Pharmacovigilance Systems
- Strengthening of PSM Services and Risk Mitigation
- UNDP Health PSM Roster
- UNDP Quality Assurance Policy and Plan
-
Reporting
- Communicating Results
- Grant Performance Report
- Overview
- Performance-based Funding and Disbursement Decision
- PR and Coordinating Mechanism (CM) Communication and Governance
- Reporting to the Global Fund
- UNDP Corporate Reporting
-
Risk Management
- Common Risks Identified in Global Fund Programmes
- Global Fund Risk Management
- Introduction to Risk Management
- Overview
- Risk Management in High Risk Environments
- Risk Management in UNDP-managed Global Fund Grants
- Risk management in UNDP
- UNDP Risk Management in the Global Fund Portfolio
- Sub-Recipient Management
Diagnostic Products
Diagnostic products procured with Global Fund resources must adhere to the Global Fund Quality Assurance (QA) Policy for diagnostic products, issued on 14 December 2010 and most recently amended on 4 May 2017.
Diagnostic products means all durable and non-durable in-vitro diagnostic products (IVD), imaging equipment and microscopes used for diagnosis, screening, surveillance or monitoring purposes.
Quality standards for diagnostic products
Section 7 of Global Fund QA Policy for diagnostics states that Grant Funds may only be used to procure diagnostic products that meet the following standards:
- IVDs and imaging equipment manufactured at a site compliant with the requirements of ISO 13485:2003 or an equivalent quality-management system recognized by one of the regulatory authorities of the Founding Members of GHTF[1]; and
- any diagnostic product for which Section 7 (i) above does not apply, such as microscopes, manufactured at a site compliant with all applicable requirements of the ISO 9000 series or an equivalentquality-management systemrecognized by one of the regulatory authorities of the founding members of GHTF.
Section 8 of the Global Fund QA Policy for diagnostics states that, in addition to the requirements of Section 7 above, diagnostics products with regards to HIV, tuberculosis and malaria and to hepatitis B, hepatitis C and syphilis co-infections, as well as IVDs providing information that is critical for patient treatment of these diseases, such as testing for G6PD deficiency, shall meet any one of the following standards:
- prequalification by the WHO Prequalification of In Vitro Diagnostics Programme; or
- for tuberculosis: recommendation by relevant WHO programme; or
- authorization for use by one of the Regulatory Authorities of the Founding Members of GHTF when stringently assessed (high risk classification)[2]; or
- acceptability for procurement using Grant Funds, as determined by the Global Fund, based on the advice of the WHO Expert Review Panel.
The quality assurance page on the Global Fund website provides further guidance on QA requirements and how to ensure that the most recent version of documents and templates are used.
[1] GHTF—the Global Harmonization Task Force—has now been replaced by IMDRF—the International Medical Devices Regulators Forum (conceived in February 2011). IMDRF members are: Australia, Brazil, Canada, China, European Union, Japan, the Russian Federation and the United States. IMDRF observers are: WHO and Asia-Pacific Economic Cooperation (APEC). IMDRF affiliates are: Asian Harmonization working party and the Pan American Health Organization (PAHO). For further information, see: http://www.imdrf.org/.
[2] This option is not applicable to RDTs for HIV-Self-Testing.
Loading resources
